Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous Interventions.
Galli M, Gragnano F, Berteotti M, Marcucci R, Gargiulo G, Calabrò P, Terracciano F, Andreotti F, Patti G, De Caterina R, Capodanno D, Valgimigli M, Mehran R, Perrone Filardi P, Cirillo P, Angiolillo DJ; Working Group of Thrombosis of the Italian Society of Cardiology. Galli M, et al. Among authors: marcucci r. JACC Cardiovasc Interv. 2024 Oct 28;17(20):2325-2336. doi: 10.1016/j.jcin.2024.09.011. JACC Cardiovasc Interv. 2024. PMID: 39477636 Review.
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators. Bhatt DL, et al. Lancet. 2019 Sep 28;394(10204):1169-1180. doi: 10.1016/S0140-6736(19)31887-2. Epub 2019 Sep 1. Lancet. 2019. PMID: 31484629 Free article. Clinical Trial.
[Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts].
Lettino M, Zambon A, Musumeci G, Arca M, Bilato C, Brunetti ND, Calabrò P, Casu G, Chiarella F, Faggiano P, Ferlini M, Guardigli G, Imbalzano E, Indolfi C, Marcucci R, Menozzi A, Mureddu GF, Filardi PP, Pirro M, Pisciotta L, Scherillo M, Suppressa P, Uguccioni M, Varbella F, Gentile L, Rapezzi C, Averna M. Lettino M, et al. Among authors: marcucci r. G Ital Cardiol (Rome). 2020 Apr;21(4 Suppl 1):3S-21S. doi: 10.1714/3331.33006. G Ital Cardiol (Rome). 2020. PMID: 32202541 Italian.
Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology.
Patti G, Cavallari I, Cesaro A, Gragnano F, Riva L, Fimiani F, Cuccia C, Fresco C, Calabrò P, Leonardi S, Marcucci R, Rubboli A. Patti G, et al. Among authors: marcucci r. Vascul Pharmacol. 2023 Feb;148:107137. doi: 10.1016/j.vph.2022.107137. Epub 2022 Dec 1. Vascul Pharmacol. 2023. PMID: 36464086 Review.
Monitoring antiplatelet therapy: where are we now?
Marcucci R, Berteotti M, Gragnano F, Galli M, Cavallari I, Renda G, Capranzano P, Santilli F, Capodanno D, Angiolillo DJ, Cirillo P, Calabrò P, Patti G, De Caterina R; Working Group of Thrombosis of the Italian Society of Cardiology. Marcucci R, et al. J Cardiovasc Med (Hagerstown). 2023 Apr 1;24(Suppl 1):e24-e35. doi: 10.2459/JCM.0000000000001406. Epub 2022 Dec 15. J Cardiovasc Med (Hagerstown). 2023. PMID: 36729588
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study.
Casula M, Gazzotti M, Capra ME, Olmastroni E, Galimberti F, Catapano AL, Pederiva C; LIPIGEN Group and the LIPIGEN Paediatric Group. Casula M, et al. Atherosclerosis. 2023 Nov;385:117231. doi: 10.1016/j.atherosclerosis.2023.117231. Epub 2023 Aug 12. Atherosclerosis. 2023. PMID: 37648636 Free article.
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy].
Arca M, Averna M, Borghi C, Lettino M, Perrone Filardi P, Alberti A, Bilato C, Calabrò P, Carubbi F, Ciccone MM, Cipollone F, Citroni N, De Luca L, Giaccari A, Iannuzzo G, Maloberti A, Marcucci R, Pignatelli Spinazzola P, Pirro M, Pisciotta L, Sarullo F, Sciacqua A, Suppressa P, Varbella F, Werba JP, Zambon A. Arca M, et al. Among authors: marcucci r. G Ital Cardiol (Rome). 2023 Oct;24(10):770-780. doi: 10.1714/4100.40977. G Ital Cardiol (Rome). 2023. PMID: 37767829 Review. Italian.
Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.
Gresele P, Guglielmini G, Del Pinto M, Calabrò P, Pignatelli P, Patti G, Pengo V, Antonucci E, Cirillo P, Fierro T, Palareti G, Marcucci R; START Antiplatelet Registry Group. Gresele P, et al. Among authors: marcucci r. Sci Rep. 2024 Jun 24;14(1):14516. doi: 10.1038/s41598-024-64113-5. Sci Rep. 2024. PMID: 38914608 Free PMC article.
ACEF vs PARIS score in Predicting Cardiovascular Events in Patients With Acute Coronary Syndrome: Insights From the START ANTIPLATELET Registry.
Cirillo P, Di Serafino L, Scalamogna M, De Rosa G, Calabrò P, Antonucci E, Gresele P, Palareti G, Patti G, Pengo V, Pignatelli P, Marcucci R. Cirillo P, et al. Among authors: marcucci r. Angiology. 2024 Aug 27:33197241278923. doi: 10.1177/00033197241278923. Online ahead of print. Angiology. 2024. PMID: 39191437
368 results